The EGFR is a receptor tyrosine kinase that is overexpressed in 30–98% of epithelial ovarian cancer [4,5] and overexpression of EGFR (and its ligands) in ovarian cancer patients correlate with poor prognosis [12]. The gene discussed is EGFR; the disease is ovarian cancer.